
This episode offers a detailed look into the FDA’s recent PCAC meeting and what the future of peptide compounding could lead to for pharmacy professionals.
Steve Postal, KD, director of policy and regulatory affairs at the National Community Pharmacists Association, shared an overview of federal- and state-level legislative, advocacy, and regulatory updates.
Steve Postal, KD, director of policy and regulatory affairs at the National Community Pharmacists Association, shared an overview of federal- and state-level legislative, advocacy, and regulatory updates that will impact affect independent pharmacies in the coming months, including PBM reform, pharmacist provider status, and the inflation reduction act.






